PGR and neoplasm: Breast cancers are now recognized as heterogeneous, based on tumor expression of receptors for estrogen (ER), progesterone (PR)—referred to jointly as hormone receptor (HR)—and human epidermal growth factor receptor 2 (HER2) [3-5].